That is, increases in the AH concentrations of TGF-β-2 or TGF-β-1 and TGF-β-2 were detected in patients with POAG [42,43] or primary angle-closure glaucoma (PACG) [44], respectively. Here, TGFB2 is linked to primary angle-closure glaucoma.